Conmed Corp (NYSE:CNMD)
| 103.11 Delayed Data As of Aug 12 |  +2.57 / +2.56%Today’s Change | 87.24 Today|||52-Week Range 159.11 | -27.26% Year-to-Date |
Latest CNMD News | Press Releases
| CONMED (CNMD) Acquires Soft Tissue Implant Start-Up Biorez Aug 10 / Zacks.com - Paid Partner Content | PDCO vs. CNMD: Which Stock Should Value Investors Buy Now? Aug 05 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 100.54 |
| Today’s open | 101.19 |
| Day’s range | 100.58 - 103.11 |
| Volume | 6,911 |
| Average volume (3 months) | 438,750 |
| Market cap | $3.0B |
Data as of 3:59pm ET, 08/12/2022
Growth & Valuation
| Earnings growth (last year) | +544.02% |
| Earnings growth (this year) | +3.89% |
| Earnings growth (next 5 years) | +11.21% |
| Revenue growth (last year) | +18.08% |
| P/E ratio | NM |
| Price/Sales | 4.49 |
| Price/Book | 3.64 |
Competitors
Data as of 3:59pm ET, 08/12/2022
Financials
| Next reporting date | October 26, 2022 |
| EPS forecast (this quarter) | $0.76 |
| Annual revenue (last year) | $1.0B |
| Annual profit (last year) | $62.5M |
| Net profit margin | 6.16% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Largo, Florida |
Forecasts
